Immuneering Corp. (IMRX)
5.33
+0.35
(+7.03%)
USD |
NASDAQ |
Mar 06, 16:00
5.315
-0.02
(-0.28%)
After-Hours: 20:00
Immuneering SG&A Expense (TTM) : 12.81M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 237.95M |
| Verastem, Inc. | 56.70M |
| Phathom Pharmaceuticals, Inc. | 279.72M |
| Tango Therapeutics, Inc. | 31.74M |
| Moderna, Inc. | 1.018B |